Total Management of Cancer Since 1969

Eliminate Cervical Cancer in India

The high incidence of 1,23,907 new cervical cancers diagnosed annually in Indian women contributes significantly to the global burden of cervical cancers. Cervical Cancers are caused by High Risk Human Papilloma Virus (HR-HPV) and 99.7% are positive for HR-HPV. The good news is that Cervical Cancer is preventable through HPV Vaccination and systematic, organized HPV screening, leading to prevention and early detection resulting in better prognosis and high rate of cure.

Cancer Patients Aid Association (CPAA) is dedicated to implementing a triple strategy aimed at eliminating cervical cancer from India. These strategies encompass:

1. Cervical Cancer awareness:

CPAA conducts interactive sessions to educate individuals about the risk factors, prevention methods, early detection modalities, and signs/symptoms of cervical cancer. By dispelling myths, misconceptions, fear, and stigma associated with cervical cancer, awareness programs have reached over 40,000 individuals.

2. Early Detection through Screening by HPV testing :

CPAA’s Hansa Dabke Cancer Awareness, prevention and Screening Center offers cutting-edge international Hybrid Capture 2 detection services for identifying high-risk HPVs. With a screening of 10,000 women for HR-HPV, our findings reveal around 8-10 % positivity rate, signaling a heightened risk of cervical cancer among these individuals. Our dedicated team counsels HPV-positive women on risk factors and early detection methods for cervical cancer, guiding them towards preventive measures. In an effort to enhance awareness and facilitate early detection, CPAA initiatives include providing free HPV tests for socioeconomically disadvantaged women and offering subsidized screening rates to corporates. These endeavors aim to empower women with knowledge, leading to improved prognoses, reduced incidence rates, and the mitigation of cervical cancer severity.

Cervical Cancer Symptoms:

  • Abnormal vaginal bleeding, bleeding between periods, after intercourse or after menopause
  • White, brown or blood stained, foul smelling vaginal discharge
  • Loss of appetite
  • Unexplained weight loss
  • Involuntary loss of urine or fecal matter

3. HPV Vaccination: A safe, efficacious vaccine providing protection against cervical cancer

HPV vaccines, such as Cervavac and Gardasil, offer safe and effective protection against cervical cancer. Administered prior to HPV infection, these vaccines are proven to be highly efficacious with no severe adverse side-effects reported. CPAA has conducted free HPV vaccination camps for eligible young girls and women from marginalized backgrounds, significantly contributing to reducing the incidence of cervical cancer.

Characteristics of HPV Vaccines:

  • Protection against Cervical Cancer
  • Proven efficacy and safety
  • 99-100% efficacy against relevant HPV types
  • Administered intramuscularly in the deltoid muscle or thigh region
  • No severe adverse side-effects reported
  • Vaccine doses administered: 350 million doses globally and 4,00,000 doses in India
  • Contraindicated in pregnant women
  • Approved by the Drug Controller of India

CPAA has conducted widespread vaccination campaigns across various states of Maharashtra, particularly targeting rural areas. These initiatives have been generously supported by corporate sponsors and have included numerous free HPV Vaccination Camps in villages throughout the region. Notably, CPAA was invited by Honorable Nitin Gadkari, Maharashtra, to organize HPV vaccination camps in Nagpur. Additionally, the Chief Minister’s Health Mission Cell at Mantralaya, Maharashtra, extended invitations for vaccination camps in Dindrud, Ahmednagar, Vairag, Solapur, and Ralegaon Siddhi. These concerted efforts not only promote awareness but also actively contribute to reducing the incidence of cervical cancers and improving the overall health outcomes of women in rural India. So far, CPAA has vaccinated around 32,000 young girls and women across Maharashtra.

Support CPAA’s Cervical Cancer HPV Screening Program:

Donate now
Cost per individual test: Rs. 1,600

CPAA’s Cervical Cancer HPV Vaccination Program:

Donate now

HPV Vaccination

Rs. 1,500 (per individual, 9 – 18 years females, Two doses) Rs. 3,000 (per individual, 18 – 45 years females, Three doses)

Recommended Vaccination Schedule
Age 9 – 21 years 21 – 45 years
Dosage one or two dose schedule for young girls and women Two doses mandatory at an interval of 6 months

(Help us keep you updated of our projects with an email about your generous donation)

Click to view a snapshot of some of the programs successfully organised by CPAA